Thanks Phaedrus - the stats are very instructive in potentially demonstrating the regulator’s blind spot. It’s an interesting angle.
Perhaps the numbers could be reproduced and framed in terms of a question to Dr. Klinker. I noticed a while back that he went straight from interning at the FDA while doing his PhD to a permanent role - yes he may have a lot of research experience, but if you pop that question and steer him towards a reality check, he might look at the numbers staring at him and start thinking about what institutional bias there might be. (I say that because I have the same worry about my son who’s gone straight from
fininishing his PhD to a pure research job.) The answer could be as simple or mundane as their adoption of the popular contempt towards a dodgy stem cell industry that has escaped regulatory scrutiny for a very long time. Sometimes it’s just useful to be able to look at things with different lenses.
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
Thanks Phaedrus - the stats are very instructive in potentially...
-
-
- There are more pages in this discussion • 786 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
1 | 2574 | 1.440 |
1 | 15000 | 1.435 |
2 | 11400 | 1.430 |
1 | 15000 | 1.425 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 14000 | 1 |
1.460 | 14000 | 1 |
1.465 | 14000 | 1 |
1.480 | 50134 | 1 |
1.485 | 40331 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |